An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice
- PMID: 21268021
- DOI: 10.1002/eji.201040983
An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice
Abstract
Introgression of a New Zealand Black (NZB) chromosome 13 interval onto a C57BL/6 (B6) background (B6.NZBc13) is sufficient to produce many hallmarks of lupus, including high-titre anti-chromatin antibody production, abnormal B- and T-cell activation, and renal disease. In this study we sought to characterize the immune defects leading to these abnormalities. By generating hematopoietic chimeras and BCR transgenic mice, we show that the congenic autoimmune phenotype can be transferred by BM cells and requires the presence of autoreactive B cells. Using the hen egg white lysozyme immunoglobulin transgenic mouse model, we demonstrate that B-cell anergy, deletion, and receptor editing are intact. Nevertheless, congenic B cells exhibit altered peripheral B-cell selection, as demonstrated by enhanced survival and activation of endogenous B cells with autoreactivity to chromatin and Sm/ribonucleoprotein. Given the autoantibody specificities to nuclear antigens, TLR signalling was assessed. B6.NZBc13 B cells were hyper-responsive to poly(I:C), a TLR3 ligand, demonstrating enhanced proliferation and survival as compared to B6 B cells. Our findings indicate the presence of an intrinsic B-cell defect on NZB chromosome 13 that results in hyper-responsiveness to a dsRNA analogue and implicates its potential supporting role in the generation of autoimmunity in B6.NZBc13 mice.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.J Immunol. 1997 Dec 15;159(12):5810-20. J Immunol. 1997. PMID: 9550377
-
Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.J Immunol. 1999 Feb 15;162(4):2415-21. J Immunol. 1999. PMID: 9973523
-
B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.J Immunol. 1998 Nov 1;161(9):4634-45. J Immunol. 1998. PMID: 9794392
-
B-cell biology and development.J Allergy Clin Immunol. 2013 Apr;131(4):959-71. doi: 10.1016/j.jaci.2013.01.046. Epub 2013 Mar 5. J Allergy Clin Immunol. 2013. PMID: 23465663 Review.
-
B-cell receptor signaling in lymphoid malignancies and autoimmunity.Adv Immunol. 2014;123:1-49. doi: 10.1016/B978-0-12-800266-7.00004-2. Adv Immunol. 2014. PMID: 24840946 Review.
Cited by
-
Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.J Biol Chem. 2012 Nov 16;287(47):39789-99. doi: 10.1074/jbc.M112.383000. Epub 2012 Sep 27. J Biol Chem. 2012. PMID: 23019335 Free PMC article.
-
Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.Arthritis Res Ther. 2018 Jan 30;20(1):13. doi: 10.1186/s13075-018-1511-5. Arthritis Res Ther. 2018. PMID: 29382365 Free PMC article.
-
The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.Mol Immunol. 2011 Oct;49(1-2):367-79. doi: 10.1016/j.molimm.2011.09.008. Epub 2011 Oct 2. Mol Immunol. 2011. PMID: 21963220 Free PMC article.
-
Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.Genes Immun. 2015 Jul-Aug;16(5):311-20. doi: 10.1038/gene.2015.17. Epub 2015 May 14. Genes Immun. 2015. PMID: 25973757
-
Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.PLoS One. 2012;7(8):e41644. doi: 10.1371/journal.pone.0041644. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952582 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases